TY - JOUR
T1 - Can psychedelic compounds play a part in drug dependence therapy?
AU - Sessa, Ben
AU - Johnson, Matthew W.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research this area.
AB - After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research this area.
UR - http://www.scopus.com/inward/record.url?scp=84920424488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84920424488&partnerID=8YFLogxK
U2 - 10.1192/bjp.bp.114.148031
DO - 10.1192/bjp.bp.114.148031
M3 - Review article
C2 - 25561484
AN - SCOPUS:84920424488
SN - 0007-1250
VL - 206
SP - 1
EP - 3
JO - British Journal of Psychiatry
JF - British Journal of Psychiatry
IS - 1
ER -